European rating of drug harms

  title={European rating of drug harms},
  author={J. V. van Amsterdam and D. Nutt and L. Phillips and W. van den Brink},
  journal={Journal of Psychopharmacology},
  pages={655 - 660}
Background: The present paper describes the results of a rating study performed by a group of European Union (EU) drug experts using the multi-criteria decision analysis model for evaluating drug harms. Methods: Forty drug experts from throughout the EU scored 20 drugs on 16 harm criteria. The expert group also assessed criteria weights that would apply, on average, across the EU. Weighted averages of the scores provided a single, overall weighted harm score (range: 0–100) for each drug… Expand
The Australian drug harms ranking study
Overall, alcohol was the most harmful drug when harm to users and harm to others was combined, followed by cigarettes, crystal methamphetamine, cannabis, heroin and pharmaceutical opioids. Expand
Ranking the harm of non-medically used prescription opioids in the UK.
The overall harms of non-medically used prescription opioids are less than half that of injected street heroin, which may give a basis for precautionary regulatory measures that should be considered if the rising trend in non-medical use of prescription opioids were to become evident in the UK. Expand
Updated Indicators to Evaluate Harmful Drug Use, in Particular, Poly-Drug Use.
It is shown that high values of poly-drug use indicators are linked to specific behaviours related to interest in school, relationship with parents and use of leisure time, consistent with previous analyses based on surveys among high school students in Italy. Expand
Toward an Improved Multi-Criteria Drug Harm Assessment Process and Evidence-Based Drug Policies
The paper concludes with outlines of substance subset-specific extensions of the MCDHS and related policy proposals in the four areas identified as generating the most controversy: non-medical use of opioids, “study aid” uses of stimulants, shifting trends in nicotine containing products, and regulation of medical and recreational uses of cannabis. Expand
Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others–A Perspective of German Addiction Medicine Experts
In Germany, alcohol and illicit drugs (including new psychoactive substances) continue to rank among the most harmful addictive substances in contrast to prescribed agents including opioid analgesics and NOAs, and current laws are incongruent with these harm rankings. Expand
Assessing the European impact of alcohol misuse and illicit drug dependence research: clinical practice guidelines and evidence-base policy
The volume of research on illicit drug addiction is commensurate to the European burden, whereas alcohol misuse is far below what is needed to curb a significant source of harm. Expand
A new approach to formulating and appraising drug policy: A multi-criterion decision analysis applied to alcohol and cannabis regulation.
The MCDA process allowed the participants to deconstruct complex drug policy issues into a set of simpler judgements that led to consensus about the results. Expand
Developing a new national MDMA policy: Results of a multi-decision multi-criterion decision analysis
Background: Ecstasy (3,4-methylenedioxymethamphetamine (MDMA)) has a relatively low harm and low dependence liability but is scheduled on List I of the Dutch Opium Act (‘hard drugs’). ConcernsExpand
Using the pharmacy retail model to examine perceptions and biases of a UK population sample towards regulation of specific psychoactive drugs
Background: Contemporary research indicates that the legal classifications of cannabis (Schedule 2, Class B), 3,4-methylenedioxymethamphetamine (MDMA) (Schedule 1, Class A) and psilocybin (ScheduleExpand
Does perception of drug-related harm change with age? A cross-sectional online survey of young and older people
This survey demonstrates that the greatest misperception was in relation to alcohol-related harms which did not change with age, and needs to be addressed through education and policies that legislate drug use. Expand


Drug harms in the UK: a multicriteria decision analysis
Improved scoring and weighting approach of MCDA increases the differentiation between the most and least harmful drugs, however, the findings correlate poorly with present UK drug classification, which is not based simply on considerations of harm. Expand
Ranking the Harm of Alcohol, Tobacco and Illicit Drugs for the Individual and the Population
Whether the legal classification of drugs in the Netherlands corresponds with the ranking of the drugs according to their science-based ranking of harm based on the scientific state of the art is evaluated. Expand
Development of a rational scale to assess the harm of drugs of potential misuse
The methodology developed and explored the feasibility of the use of a nine-category matrix of harm, with an expert delphic procedure, to assess the harms of a range of illicit drugs in an evidence-based fashion and yielded roughly similar scores and rankings of drug harm when used by two separate groups of experts. Expand
The high harm score of alcohol. Time for drug policy to be revisited
Policy measures should, in addition to regulatory measures to reduce alcohol use, aim at closing the treatment gap and improving treatment effectiveness of people with an alcohol use disorder, according to the key message. Expand
Basing drug scheduling decisions on scientific ranking of harmfulness: false promise from false premises.
It is suggested that multiple dimensions of harm need to be displayed to inform human judgments of what drugs should be scheduled and not just a single measure of harmfulness. Expand
Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders
The burden of mortality and disease attributable to alcohol, both globally and for ten large countries, is quantified and concludes that alcohol consumption is one of the major avoidable risk factors, and actions to reduce burden and costs associated with alcohol should be urgently increased. Expand
Advances in decision analysis : from foundations to applications
The Foundations of Decision Analysis Revisited and A Personal Account of How It Got Started and Evolved are presented. Expand
Decision conferencing
  • 2007